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INTRODUCTION 
PHARMACEUTICAL ANALYSIS:  
Pharmaceutical Analysis is the branch of chemistry involved in separating, identifying 
and determining the relative amounts of the components making up a sample of matter. It 
is mainly involved in the qualitative identification or detection of compounds and 
quantitative measurements of the substances present in bulk and pharmaceutical 
preparation. Analytical instrumentation plays an important role in the production and 
evaluation of new products and in the protection of consumers and the environment. This 
instrumentation provides the lower detection limits required to assure safe foods, drugs, 
water and air. (Connors KA (1994) 
Types 
 
There are main two types of pharmaceutical analysis. 
1. Qualitative (identification)  
2. Quantitative (estimation) 
 
1. Qualitative analysis is performed to establish composition of natural/synthetic 
substances. These tests are performed to indicate whether the substance or compound is 
present in the sample or not. It is mainly used in the determination of assay of samples. 
 
2. Quantitative analytical techniques are mainly used to quantify any compound 
or substance in the sample. It is mainly used in the degradation studies to determine the 
amount of drug and degraded products present in the sample. (Sharma BK (2000) 
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Various types of Qualitative analysis:  
1. Chemical methods 
                 a) volumetric or titrimetric methods 
                 b) gravimetric methods 
                 c) gasometric analysis 
2.Electrical methods 
3.Instrumental methods 
4.Biological and microbiological. 
 
DEGRADATION STUDIES: 
The stability of a drug product or a drug substance is a critical parameter which may 
affect purity, potency and safety. Changes in drug stability can risk patient safety by 
formation of a toxic degradation product(s) or deliver a lower dose than expected. 
Therefore it is essential to know the purity profile and behavior of a drug substance under 
various environmental conditions. 
Forced degradation studies are carried out for the following reasons: 
• To develop and validate a stability indicating method 
• To determine degradation pathways of drug substances and drug products  
            (E.g. during development phase)  
• To identify impurities related to drug substances or excipients 
• To understand the drug molecule chemistry 
• To generate more stable formulations 
•          To generate a degradation profile that mimics what would be observed in a formal  
            stability study under ICH conditions.             
•           To solve stability-related problems (e.g., mass balance) 
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In order to monitor possible changes to a product over time, the applied analytical 
method (in most cases a chromatographic method) must be stability-indicating; the best 
case for testing the suitability of a method is using real-time stability samples containing 
all relevant degradation products that might occur. But due to product development 
timelines, process characteristics, excipients, and other environmental factors, a forced 
degradation study (stress test) can serve as an alternative. In a typical study, relevant 
stress conditions are light, heat, humidity, hydrolysis (acid / base influence) and oxidation 
or even a combination of described parameters. The formation of degradation products, 
independent of the strength of stress conditions can vary due to the chemical nature of the 
drug substance, the kind of drug product, and product specific storage requirements. An 
individual program has to be set up in order to reach a target degradation of 5 to 20%. A 
higher level of degradation will be out of the scope of product stability requirements and 
therefore unrealistic. The scope of the test is to generate degradation products in order to 
facilitate a method development for determination of the relevant products.  
(Sandor Gorog (2006) 
 
IMPURITY PROFILING 
 
The definition of the impurity profile of a new drug material as given in the guidelines of 
ICH is ‘‘A description of the identified and unidentified impurities, present in a new drug 
substance’’. As for impurity profiling, it is the common name attributed to analytical 
activities performed with the aim of detecting, identifying or elucidating the structure and 
quantitatively determining organic and inorganic impurities as well as residual solvents in 
bulk drugs and pharmaceutical formulations. 
 
The aim is to minimize the adverse effects of drug materials and the preparations made 
thereof. After establishing the pharmacological-toxicological profile of a drug substance, 
pharmacologists, clinicians and drug-registration authorities consider the beneficial and 
adverse effects to human and, on the basis of the benefit/risk ratio thus obtained, make 
the decision of introducing the drug substance into therapy. In principle, the adverse 
effects can originate from two sources: 
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 It is well known that, in addition to their beneficial effects, all drug materials have 
adverse (side) effects, which can be considered inherent properties and cannot be 
influenced by the quality of the drug material and 
 
 If the impurities of a drug material (the difference between 100% and the 98–99% 
mentioned above) are physiologically highly active (toxic) materials, in principle, 
they could contribute to the side-effect profile of the drug. Since the impurity profile 
of a drug material depends on the synthesis route and other factors, this could make 
the side-effect profile irreproducible, adversely influencing the safety of drug therapy. 
By estimating the impurity profile of a drug material and setting strict limits for the 
impurities, this danger can be minimized. (Saranjit Singh et al., (2000) 
 
 
CHARACTERISATION OF DEGRADED PRODUCTS  
 
The characters of the degraded fragments were studied by both Spectrophotometric 
methods and chromatographic techniques. The degraded products were analyzed by 
following methods.  
 UV spectroscopy 
 INFRARED spectroscopy 
 TLC 
 HPLC 
 
These methods were used to determine the assay and the amount of sample present in the 
degraded products and also used in identification of impurities. 
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FORCED DEGRADATION FLOW CHART 
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DEGRADATION USING 
0.1N NaOH, HCl, 10% H2O2 
0.01N NaOH, HCl, 
3% H2O2 
1N NaOH, HCl, 
20% H2O2 
2N NaOH, HCl, 
30% H2O2 
5N NaOH, HCl, 
40% H2O2 
PRACTICALLY 
STABLE 
 
CARRY OUT UNDER 
MILD CONDITIONS 
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DRUG PROFILE 
 
DRUG NAME     : CEFUROXIME AXETIL 
BRAND NAME   : Ceftin 500mg 
IUPAC NAME              :1-Acetoxyethyl(6R,7R)-3[(carbamoyloxy)methyl]-
7-{[(2Z)-2-(2-furyl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-
azabicyclo[4.2.0]oct-2-ene-2-carboxylate. 
MOLECULAR FORMULA  : C20H22N4O10S    
MOLECULAR WEIGHT              : 510.475 g/mol 
CAS NUMBER              : 64544-07-6 
CHEMICAL STRUCTURE             :  
                          
BASIC MOIETY                               : Beta-Lactam 
CATEGORY    : Second Generation Cephalosporin Antibiotic 
DESCRIPTION    : A white or almost white powder 
SOLUBILITY    : Slightly soluble in water, soluble in acetone, in 
ethyl acetate and in methanol, slightly soluble in alcohol. 
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MECHANISM OF ACTION      
 Cefuroxime axetil is a semi synthetic cephalosporin antibiotic, chemically similar to 
penicillin. Cephalosporins stop or slow the growth of bacterial cells by preventing 
bacteria from forming the cell wall that surrounds each cell. The cell wall protects 
bacteria from the external environment and keeps the contents of the cell together. 
Without a cell wall, bacteria are not able to survive. Cefuroxime is effective against a 
wide variety of bacteria, such as Staphylococcus aureus, Streptococcus pneumoniae, 
Haemophilus influenzae, E. coli, N. gonorrhea, and many others. The FDA approved 
Cefuroxime in December 1987. 
INDICATIONS 
Cefuroxime is effective against susceptible bacteria causing infections of the middle ear 
(otitis media), tonsillitis, throat infections, laryngitis, bronchitis, and pneumonia. It also is 
used for treating urinary tract infections, skin infections, and gonorrhea. Additionally, it 
is useful in treating acute bacterial bronchitis in patients with chronic obstructive 
pulmonary disease (COPD). 
DRUG INTERACTIONS 
 Probenecid increases the concentration of Cefuroxime in the blood. Drugs that reduce 
acidity in the stomach (for example, antacids, H2-blockers, proton pump inhibitors) may 
reduce absorption of Cefuroxime. 
PREGNANCY:  
Cephalosporins are usually considered safe for use during pregnancy. 
 
NURSING MOTHERS: 
 Cefuroxime is excreted in breast milk and may cause adverse effects in the infant. 
Cefuroxime is approved for pediatric patients 3 months and older. 
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SIDE EFFECTS:  
Cefuroxime is generally well tolerated, and side effects are usually transient. Side effects 
include diarrhea, nausea, and vomiting, abdominal pain, headache, rash, and 
hives, vaginitis, and mouth ulcers. Allergic reactions, severe skin reactions, anemia, 
and seizures also may occur.  
 
DOSING:  
Typical adult oral doses are 250 or 500 mg twice daily for 7-20 days depending on the 
type and severity of the infection. A single 1000 mg dose may used for uncomplicated 
gonorrhea. The tablets and suspension are not interchangeable. (www.rxlist.com) 
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REVIEW OF LITERATURE 
 
 Connors KA (1994) A Textbook of Pharmaceutical Analysis. 
 
 Saranjit Singh et al., (2000) have listed out the possible benefits of forced degradation 
studies to assess the stability of drugs and products.  
 
 Sharma BK (2000) Instrumental methods of chemical analysis. 
 
 Marianna Zajac et al., (2003) investigated the effect of temperature and relative 
atmospheric humidity on the stability of the crystalline form of cefuroxime axetil in solid 
state. Changes in the concentration of cefuroxime axetil were recorded by means of 
HPLC with UV detection. 
 
 Jain Pritam et al., (2004) developed a validated UV-Spectrophotometric method for 
determination of Cefuroxime Axetil in bulk and in Formulation. The λ max of 
Cefuroxime axetil in 0.1N HCL was found to be 281 nm. The proposed method was 
applied to pharmaceutical formulation and percentage amount of drug estimated 99.19 % 
was found in good agreement with the label claim. 
 
 Ivanovic Ivana et al., (2006) determined the assay of cefuroxime axetil after accelerated 
stability conditions. The study includes the methods to determine the assay of cefuroxime 
axetil bulk and formulation in various conditions like temperature, humidity and alkali 
hydrolysis. 
 
 Steven W. Baertschi (2006) has reported the information for discovering and profiling 
degradation-related impurities. He also reported the technologies, their strengths and 
limitations, and recommends strategies for successful DRI profiling. 
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 SV Chaudhari  et al., (2006) carried out the Simultaneous UV spectrophotometric 
method for the estimation of cefuroxime axetil and probenecid from solid dosage forms. 
 
 Sandor Gorog (2006) have reported the importance and the challenges of impurity 
profiling in modern pharmaceutical analysis. 
 
 MV Shinde et al., (2008) developed a spectrophotometric determination of cefuroxime 
axetil from bulk and in its tablet dosage form.  
 
 Santosh shelke et al., (2009) developed a Validated UV spectrophotometric method of 
Cefuroxime axetil in bulk and pharmaceutical formulation which is based on 
measurement of absorption at maximum wavelength 281nm. 
 
 Gandhi Santosh V et al., (2009) have developed a Simultaneous determination of 
Cefuroxime axetil and ornidazole in tablet dosage form using reversed-phase high 
performance liquid chromatography. 
 
 Michae Kaza et al., (2010) developed the validated HPLC method for determination of 
cefuroxime in human plasma. 
 
 M.D.Game et al., (2010) developed a Validated 1st order derivative spectroscopy for the 
determination of cefuroxime axetil in bulk drug and tablets. 
 
 P Santhosh Kumar et al., (2012) have reported a Validated High Performance Liquid 
Chromatography method for the estimation of cefuroxime axetil. 
 
 NJ Shah et al., (2012) have reported a development and validation of a HPTLC method 
for the estimation of cefuroxime axetil. 
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 K. A. Shaik et al., (2011) have developed a specific stability indicating assay method for 
the determination of cefuroxime sodium in pharmaceutical formulation by UV-VIS 
spectrophotometer.  
 
 P. N. Patil et al., (2012) reported a HPLC analysis method of cephalosporins and study 
of different analytical parameters. 
 
 Pramod L. Ingale et al., (2013) developed the simultaneous determination of cefuroxime 
axetil and potassium clavulanate in pharmaceutical dosage form by RP-HPLC. 
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AIM AND OBJECTIVE 
 
The stability of a drug product or a drug substance is a critical parameter which may 
affect purity, potency and safety. Changes in drug stability can risk patient safety by 
formation of a toxic degradation product(s) or deliver a lower dose than expected. 
Therefore it is essential to know the purity profile and behavior of a drug substance under 
various environmental conditions 
The aim of the study is to conduct “FORCED DEGRADATION STUDIES OF 
CEFUROXIME AXETIL IN BULK AND FORMULATION BY UV, IR 
SPECTROPHOTOMETRY, TLC, AND RP-HPLC METHOD” and to evaluate the 
stability of Cefuroxime axetil in variety of stress conditions. Stability plays an important 
role in storage of drugs.   
The study includes the following  
 To perform the Alkali hydrolysis, Oxidative degradation, and Thermal and 
Photolytic degradation. 
 Quantification of degraded product by UV and HPLC. 
 Comparing the results of bulk and sample with standard. 
 Identification of Degraded samples by TLC. 
 Identification of changes in functional group present in the degraded samples by 
IR. 
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MATERIALS AND METHODS 
             DRUG SAMPLE & STUDY PRODUCTS 
                Cefuroxime axetil bulk was obtained from Orchid Healthcare, Chennai, and Tamilnadu. 
            Test product:  
Cefuroxime axetil tablets (Ceftin 500mg) were purchased from medical shop.  
            CHEMICALS AND SOLVENTS USED FOR DEGRADATION: 
 Hydrochloric Acid            – Merck, AR grade, Mumbai, India. 
 Hydrogen Peroxide (30%W/V)   – Merck, AR grade, Mumbai, India. 
 Sodium Hydroxide                      – Merck, AR grade ,  Mumbai, India 
 Chloroform                                 – Merck, AR grade , Mumbai, India 
 Ethanol                                        – Merck, AR grade , Mumbai, India 
 Methanol                                      – Merck, HPLC grade, Mumbai, India 
 Acetonitrile                                – Merck, HPLC grade, Mumbai, India 
 Water                                          – Double Distilled     
  
 INSTRUMENTS USED: 
 Shimadzu 1650 UV Spectrophotometer    –  Double beam , UV Probe2.31 
 ABB-IR   ,KBr Press                                 –  AB MB 3000 
 Agilent HPLC                                            – VWD detector, Chemstation 
 Shimadzu electronic balance                     – AX 200  
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FORCED DEGRADATION 
Forced degradation studies are used to identify reactions which may occur to degrade a 
processed product. Usually conducted before final formulation, forced degradation uses 
external stresses to rapidly screen material stabilities. Forced degradation was performed 
in various conditions to detect the stability of a drug and drug products. Forced 
degradation plays a role in the storage of drug products. (Sandor Gorog (2006) 
ANALYTICAL PROCEDURES 
Degraded samples were analyzed using Spectrophotometric methods like UV, IR and 
chromatographic methods like TLC and HPLC. The assays of degraded samples were 
carried out by UV and HPLC and the changes in the functional group of drug were 
detected by IR spectroscopy. Degraded products were identified by TLC. 
HYDROLYTIC DEGRADATION 
Hydrolysis usually means the cleavage of chemical bonds by the addition of water. The 
main source of impurities in the formulations is from hydrolytic degradation. Water 
either as a solvent or as moisture in the air comes in contact with pharmaceutical dosage 
forms is responsible for degradation of most of the drugs. Hydrolytic study under acidic 
and basic condition cleavage of Beta lactum ring present in the Cefuroxime axetil. NaOH 
and HCl are employed for generating acidic and basic stress samples respectively. 
The hydrolytic degradation of a new drug in acidic and alkaline condition can be studied 
by treating the drug with 0.1N NaOH /0.1N HCl. If sufficient degradation is not 
observed, higher strength of reagents are employed to induce degradation (1N 
NaOH/1NHCl). (Saranjit Singh et al., (2000) 
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OXIDATIVE DEGRADATION  
The increase in oxidation state of an atom through a chemical reaction is known as an 
oxidation. Most of the drugs undergo auto oxidation because of oxygen in air. Therefore 
it is an important degradation pathway of many drugs. Auto oxidation is a free radical 
reaction that requires free radical initiator to begin the chain reaction. Hydrogen 
peroxide, metal ions in a drug substance act as initiators for auto oxidation. Hydrogen 
peroxide is a common oxidant to produce oxidative degradation products which may 
arise as minor impurities during long term stability studies. Hydrogen peroxide seems to 
be much more popular for the purpose than any other oxidizing agent. The strength of 
H2O2 used varies from 1% to 30%. In some drugs extensive degradation is seen when 
exposed to 3% H2O2 for very short time periods at room temperature. In other cases, 
exposure to high concentrations of H2O2 even under extreme conditions does not cause 
any significant degradation. The behavior is on expected lines, as some drugs are in fact 
oxidisable, while there are others that are not. The latter are not expected to show any 
change even in the presence of high dose of oxidizing agents. 
 
THERMAL DEGRADATION  
Temperature also plays a role in degradation of drugs. High temperature leads to increase 
in degradation of drugs. Most of the drugs are sensitive to temperature. Thermal 
degradation can cause reactions like pyrolysis, hydrolysis, decarboxylation, 
isomerization, rearrangement and polymerization. 
PHOTOLYTIC DEGRADATION  
Exposure of Sun light to drug is called photolytic degradation. The rate of degradation is 
directly proportional to the intensity, quantity of sun light absorbed by the drug. It is 
carried out by exposing the drug substance and drug product to a sun light. (ICH 
Guidelines) 
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1. UV SPECTROSCOPY 
UV refers to absorption spectroscopy spectroscopy in the ultraviolet spectral region. This 
means it uses light in the visible and adjacent (near-UV and near-infrared (NIR)) ranges. 
The absorption in the visible range directly affects the perceived color of the 
chemicals involved. In this region of the electromagnetic spectrum, 
molecules undergo electronic transitions. Molecules containing pi-electrons or non-
bonding electrons (n-electrons) can absorb the energy in the form of ultraviolet or visible 
light to excite these electrons to higher anti-bonding molecular orbitals. The more easily 
excited the electrons the longer the wavelength of light it can absorb. In degradation 
studies UV plays one of the roles in detection of impurities. Assay values of drug 
products can be calculated using UV spectroscopy. In ultra violet region every molecule 
will give its own absorption at particular wavelength this is called λmax. Every 
compound has unique λmax and absorption. Absorption value varies only with the 
concentration of the compound. Degraded samples spectrum can be compared with 
standard spectrum to identify the degradation. After degradation the absorption and the 
λmax of the samples can vary from the standard. This shows the degradation of samples. 
Materials and Methods 
All absorption spectrums were measured by Shimadzu UV-1650PC spectrophotometer 
with 1cm matched quartz cells. 
Reagents used 
0.1N Sodium hydroxide 
0.1N Hydrochloric acid 
30% Hydrogen peroxide 
Ethanol 
Distilled water 
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 PREPARATION OF REAGENTS 
 Preparation of 0.1N Sodium Hydroxide: 
4gms of sodium hydroxide pellets were weighed and dissolved in small amount of 
distilled water then made up the volume to 1000mL. 
Preparation of 0.1N Hydrochloric acid 
8.33mL of concentrated Hydrochloric acid was measured and diluted with distilled water 
to 1000mL. 
Preparation of 30% Hydrogen peroxide 
300 mL of Hydrogen peroxide was diluted with distilled water and the volume made up 
to 1000mL. 
 
Intraday scheme UV-study of Bulk & Formulation (Table: 1) 
DEGRADATION 
TYPE 
EXPERIMENTAL 
CONDITIONS 
STORAGE 
CONDITION 
SAMPLING 
TIME 
 Control Sample Room Temperature 30,60,90mins 
 
 
Hydrolysis 
0.1N NaOH Room Temperature 30,60,90mins 
0.1N HCl Room Temperature 30,60,90mins 
Acid Control Room Temperature 30,60,90mins 
Base Control Room Temperature 30,60,90mins 
 
Oxidation 
30% H2O2 Room Temperature 30,60,90mins 
30% H2O2(no API) Room Temperature 30,60,90mins 
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Interday scheme UV-study of Bulk & Formulation (Table: 2) 
 
 
 
 
 
 
 
 
INTRADAY STUDY OF HYDROLYTIC DEGRADATION USING                               
0.1N NaOH 
Standard preparation  
Cefuroxime axetil was transferred to volumetric flask and dissolved in ethanol to achieve 
a concentration of 1mg/mL. The solution was kept at room temperature. An aliquot 
solution was diluted with distilled water to get a final concentration of 10µg/mL. The 
solution was scanned in the UV region and the maximum absorbance was recorded at 
278nm. 
Bulk preparation (stress) 
50mg of Cefuroxime axetil bulk was weighed and transferred to volumetric flask; 
dissolved 0.1N NaOH to achieve a concentration of 1mg/mL. The solution was kept at 
room temperature.   After 30mins, an aliquot solution was diluted with distilled water to 
get a final concentration of 10µg/mL. The solution was scanned in the UV region and the 
maximum absorbance was recorded at 278nm. The same procedure was repeated for 
60mins, and 90mins time interval. 
DEGRADATION 
TYPE 
EXPERIMENTAL 
CONDITIONS 
STORAGE 
CONDITION 
SAMPLING 
TIME 
 Control Sample Room Temperature 1,3,5 days 
 
 
Hydrolysis 
0.1N NaOH Room Temperature 1,3,5 days 
0.1N HCl Room Temperature 1,3,5 days 
Acid Control Room Temperature 1,3,5 days 
Base Control Room Temperature 1,3,5 days 
 
Oxidation 
30% H2O2 Room Temperature 1,3,5 days 
30% H2O2(no API) Room Temperature 1,3,5 days 
Thermal Heating Chamber 50ºC 1,3,5 days 
Photolytic  Sunlight 1,3,5 days 
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Sample preparation (stress) 
50mg equivalent of Cefuroxime axetil tablets were crushed weighed and transferred to 
volumetric flask; dissolved 0.1N NaOH to achieve a concentration of 1mg/mL. The 
solution was kept at room temperature.  After 30mins, an aliquot solution was diluted 
with distilled water to get a final concentration of 10µg/mL. The solution was scanned in 
the UV region and the maximum absorbance was recorded at 278nm. The same 
procedure was repeated for 60mins, and 90mins time interval. 
Blank preparation 
50mL of 0.1N NaOH solution was taken in a 50mL volumetric flask. The solution was 
kept at room temperature. After 30mins, an aliquot solution was diluted with distilled 
water to get a final concentration. This is used as a blank. 
The procedure was repeated thrice. After the stipulated time, the absorption of the 
resulting solution showed maxima 278nm against reagent blank treated in the same way. 
Three such determinations were made and the assay value was estimated.  
(Jain Pritam et al., (2004) 
The percentage content of bulk was determined by following formula 
	
 =
	.× .	 × . 
 × 	
	.× 
. .× .	 × 
 
The amount of present was determined by following formula 

	 = 	
	.× .	 × . 
 × 	
	.		 × .	
	
. .× .	 × 
 
 
Percentage content of Cefuroxime axetil was determined by following formula 
 
	
 =

	
	
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HYDROLYTIC DEGRADATION USING 0.1N HCl 
 
Bulk preparation (stress) 
50mg of Cefuroxime axetil was transferred to volumetric flask and dissolved in 10 mL of 
ethanol, and then 0.1N Hydrochloric acid was added to achieve a concentration of 
1mg/mL. The solution was kept at room temperature. After 30mins, an aliquot solution 
was diluted with distilled water to get a final concentration of 10µg/mL. The solution was 
scanned in the UV region and the maximum absorbance was recorded at 278nm. The 
same procedure was repeated for 60mins, and 90mins time interval. 
Sample preparation (stress) 
50mg equivalent of Cefuroxime axetil tablets were crushed weighed and transferred to 
volumetric flask; dissolved in 10 mL of ethanol. Then 0.1N Hydrochloric acid was added 
to achieve a concentration of 1mg/mL. The solution was kept at room temperature. After 
30mins, an aliquot solution was diluted with distilled water to get a final concentration of 
10µg/mL. The solution was scanned in the UV region and the maximum absorbance was 
recorded at 278nm. The same procedure was repeated for 60mins, and 90mins time 
interval. 
Blank preparation 
50mL of 0.1N NaOH solution was taken in a 50mL volumetric flask. The solution was 
kept at room temperature. After 30mins, an aliquot solution was diluted with distilled 
water to get a final concentration. This is used as a blank. 
The procedure was repeated thrice. After the stipulated time, the absorption of the 
resulting solution showed maxima 278nm against reagent blank treated in the same way. 
Three such determinations were made and the assay value was estimated. The obtained 
values were tabulated. 
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OXIDATIVE DEGRADATION USING 30% H2O2 
Bulk preparation (stress)  
50mg of Cefuroxime axetil was transferred to volumetric flask and dissolved in 10 mL of 
ethanol to dissolve the drug substance, and then 30% Hydrogen peroxide was added to 
achieve a concentration of 1mg/mL. The solution was kept at room temperature. After 
30mins, an aliquot solution was diluted with distilled water to get a final concentration of 
10µg/mL. The solution was scanned in the UV region and the maximum absorbance was 
recorded at 278nm. The same procedure was repeated for 60mins, and 90mins time 
interval. 
Sample preparation (stress) 
50mg equivalent of Cefuroxime axetil tablets were crushed weighed and transferred to 
volumetric flask; dissolved in 10 mL of ethanol to dissolve the drug product, and then 
30% Hydrogen peroxide was added to achieve a concentration of 1mg/mL. The solution 
was kept at room temperature. After 30mins, the solution was scanned in the UV region 
and the maximum absorbance was recorded at 278nm. The same procedure was repeated 
for 60mins, and 90mins time interval. 
Blank preparation 
50mL of 30% H2O2solution was taken in a 50mL volumetric flask. The solution was kept 
at room temperature. After 30mins, an aliquot solution was diluted with distilled water to 
get a final concentration. This is used as a blank. 
The procedure was repeated thrice. After the stipulated time, the absorption of the 
resulting solution showed maxima 278nm against reagent blank treated in the same way. 
Three such determinations were made and the assay value was estimated. The obtained 
values were tabulated. 
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INTERDAY FORCED HYDROLYTIC DEGRADATION USING 0.1N NaOH 
 
Bulk preparation (stress) 
50mg of Cefuroxime axetil was transferred to volumetric flask and dissolved 0.1N NaOH 
to achieve a concentration of 1mg/mL. The solution was kept at room temperature. Then 
the next day, an aliquot solution was diluted with distilled water to get a final 
concentration of 10µg/mL. The solution was scanned in the UV region and the maximum 
absorbance was recorded at 278nm. The same procedure was repeated for 3rd and 5th day 
time interval. The obtained spectrum is compared with standard spectrum. 
Sample preparation (stress) 
50mg equivalent of Cefuroxime axetil tablets were crushed weighed and transferred to 
volumetric flask; dissolved 0.1N NaOH to achieve a concentration of 1mg/mL. The 
solution was kept at room temperature. Then the next day (1st day), an aliquot solution 
was diluted with distilled water to get a final concentration of 10µg/mL. The solution was 
scanned in the UV region and the maximum absorbance was recorded at 278nm. The 
same procedure was repeated for 3rd and 5th day time interval. 
Blank preparation 
50mL of 0.1N NaOH solution was taken in a 50mL volumetric flask. The solution was 
kept at room temperature. The next day, an aliquot solution was diluted with distilled 
water to get a final concentration. This procedure is repeated for 3rd and 5th day. 
The procedure was repeated thrice. After the stipulated time, the absorption of the 
resulting solution showed maxima 278nm against reagent blank treated in the same way. 
Three such determinations were made and the assay value was estimated.  
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HYDROLYTIC DEGRADATION USING 0.1N HCl 
Bulk preparation (stress) 
50mg of Cefuroxime axetil was transferred to volumetric flask and dissolved in 10 mL of 
ethanol, and then 0.1N Hydrochloric acid was added to achieve a concentration of 
1mg/mL. The solution was kept at room temperature. Then the next day, an aliquot 
solution was diluted with distilled water to get a final concentration of 10µg/mL. The 
solution was scanned in the UV region and the maximum absorbance was recorded at 
278nm. The same procedure was repeated for 3rd and 5th day time interval. The obtained 
spectrum is compared with standard spectrum. 
 
Sample preparation (stress) 
50mg equivalent of Cefuroxime axetil tablets were crushed weighed and transferred to 
volumetric flask. It was dissolved in 10 mL of ethanol, and then 0.1N Hydrochloric acid 
was added to achieve a concentration of 1mg/mL. The solution was kept at room 
temperature. The next day (1st day), an aliquot solution was diluted with distilled water to 
get a final concentration of 10µg/mL. The solution was scanned in the UV region and the 
maximum absorbance was recorded at 278nm. The same procedure was repeated for 3rd 
and 5th day time interval. 
Blank preparation 
50mL of 0.1N HCl solution was taken in a 50mL volumetric flask. The solution was kept 
at room temperature. The next day, an aliquot solution was diluted with distilled water to 
get a final concentration. This procedure is repeated for 3rd and 5th day. 
The procedure was repeated thrice. After the stipulated time, the absorption of the 
resulting solution showed maxima 278nm against reagent blank treated in the same way. 
Three such determinations were made and the assay value was estimated. 
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OXIDATIVE DEGRADATION USING 30%H2O2 
Bulk preparation (stress) 
50mg of Cefuroxime axetil was weighed and transferred to volumetric flask and 
dissolved in 10 mL of ethanol, and then 30% Hydrogen peroxide was added to achieve a 
concentration of 1mg/mL. The solution was kept at room temperature. Then the next day, 
an aliquot solution was diluted with distilled water to get a final concentration of 
10µg/mL. The solution was scanned in the UV region and the maximum absorbance was 
recorded at 278nm. The same procedure was repeated for 3rd and 5th day time interval. 
The obtained spectrum is compared with standard spectrum. 
Sample preparation (stress) 
50mg equivalent of Cefuroxime axetil tablets were crushed weighed and transferred to 
volumetric flask. It was dissolved in 10 mL of ethanol, and then 30% Hydrogen peroxide 
was added to achieve a concentration of 1mg/mL. The solution was kept at room 
temperature. The next day (1st day), an aliquot solution was diluted with distilled water to 
get a final concentration of 10µg/mL. The solution was scanned in the UV region and the 
maximum absorbance was recorded at 278nm. The same procedure was repeated for 3rd 
and 5th day time interval. 
Blank preparation 
50mL of 30% Hydrogen peroxide solution was taken in a 50mL volumetric flask. The 
solution was kept at room temperature. The next day, an aliquot solution was diluted with 
distilled water to get a final concentration. This procedure is repeated for 3rd and 5th day. 
The procedure was repeated thrice. After the stipulated time, the absorption of the 
resulting solution showed maxima 278nm against reagent blank treated in the same way. 
Three such determinations were made and the assay value was estimated. 
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THERMAL DEGRADATION AT 50ºC 
Bulk preparation (stress) 
1g of Cefuroxime axetil bulk was weighed and transferred to a petri dish. This petri dish 
was placed in a hot air over at the temperature of 50ºC. The next day 50mg Cefuroxime 
axetil bulk was weighed from a petri dish and transferred to 50mL volumetric flask. It 
was dissolved in ethanol and the volume made up to 50mL. An aliquot solution was 
diluted with distilled water to get a final concentration of 10µg/mL. The same procedure 
was repeated for 3rd and 5th day. 
Sample preparation (stress) 
1g of Cefuroxime axetil tablets were crushed weighed and transferred to a petri dish. This 
petri dish was placed in a hot air over at the temperature of 50ºC. The next day 50mg 
equivalent of Cefuroxime axetil tablet powder was weighed from a petri dish and 
transferred to 50mL volumetric flask. It was dissolved in ethanol and the volume made 
up to 50mL. An aliquot solution was diluted with distilled water to get a final 
concentration of 10µg/mL. The same procedure was repeated for 3rd and 5th day.  
Blank preparation 
Distilled water was used as a blank. 
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PHOTOLYTIC DEGRADATION USING SUN LIGHT 
Bulk preparation (stress) 
1g of Cefuroxime axetil bulk was weighed and transferred to a petri dish. This petri dish 
was placed under a sun light. The next day 50mg Cefuroxime axetil bulk was weighed 
from a petri dish and transferred to 50mL volumetric flask. It was dissolved in ethanol 
and the volume made up to 50mL. An aliquot solution was diluted with distilled water to 
get a final concentration of 10µg/mL. The same procedure was repeated for 3rd and 5th 
day.  
Sample preparation (stress) 
1g of Cefuroxime axetil tablets were crushed weighed and transferred to a petri dish. This 
petri dish was placed under a sun light. The next day 50mg equivalent of Cefuroxime 
axetil was taken from the petri dish and transferred to 50mL volumetric flask. It was 
dissolved in ethanol and the volume made up to 50mL. An aliquot solution was diluted 
with distilled water to get a final concentration of 10µg/mL. The same procedure was 
repeated for 3rd and 5th day.  
Blank preparation 
Distilled water was used as a blank. 
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2. INFRARED SPECTROCOPY 
Infrared spectroscopy is the spectroscopy that deals with the infrared region of 
the electromagnetic spectrum, which is light with a longer wavelength and 
lower frequency than visible light. The infrared portion of the electromagnetic spectrum 
is usually divided into three regions; the near-, mid- and far- infrared, named for their 
relation to the visible spectrum. The IR region is mainly divided into two types 
 Finger print region (1500-400cm-1) 
This will vary for every compound. In degradation studies this region can show a 
complete degradation of a sample otherwise no changes in the finger print region. 
 Functional group region (4000-1500cm-1) 
This will give the peaks based on the functional group present in the compound. 
In degradation studies it can show the changes in functional groups. Standard can 
be compared samples to detect the changes after the degradation. 
IR spectroscopy is mainly used in thermal and photolytic degradation studies. 
Apparatus  
All spectral measurements were made on ABB-IR (model no.MB3000) with KBr press 
(model no. M15). 
Interday scheme of IR-study for Bulk & Formulation (Table: 3) 
DEGRADATION 
TYPE MATERIAL(SOLID) 
STORAGE 
CONDITION SAMPLING TIME 
Normal 
Bulk Room temperature 1,3,5days 
Sample Room temperature 1,3,5days 
Photolysis 
Bulk Sunlight 1,3,5days 
Sample Sunlight 1,3,5days 
Thermal(Heating 
Chamber) 
Bulk 50ºC 1,3,5days 
Sample 50ºC 1,3,5days 
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2.1 INTERDAY STUDY OF CEFUROXIME AXETIL BY IR 
General Procedure 
Cefuroxime axetil tablets were weighed and transferred into petri dish. The first one was 
kept at room temperature, the second one was kept at chamber at 50ºC, and the third one 
was kept at sunlight. This was referred as 0 day. The bulk drug was weighed and 
transferred into 3 different Petri dishes. The same procedure was repeated for bulk drug. 
Standard preparation (stress) 
The first day standard of the Cefuroxime axetil was weighed and reground with dry KBr 
using agate mortar and pestle. The KBr discs were prepared by using KBr pellet press 
instrument. Then the percentage transmittance of the standard was measured. The same 
procedure was repeated for 3rdand 5rdday. The percentage transmittance was recorded in 
similar way. 
Bulk preparation (stress) 
The next day, required bulk drug has been taken from petri dish. The required amount of 
bulk drug was reground with dry KBr using agate mortar and pestle. The discs were 
prepared by using KBr press instrument. Then the percentage transmittance of the bulk 
drug was measured. The spectrum obtained from degraded sample was compared with 
standard spectrum. The same procedure was repeated for 3rd and 5th day. The percentage 
transmittance was recorded in similar way. 
Sample preparation (stress) 
The next day (1st) day, required sample has been taken from petri dish. The required 
amount of sample was reground with dry KBr using agate mortar and pestle. The discs 
were prepared by using KBr press instrument. Then the percentage transmittance of the 
sample was measured. The same procedure was repeated for 3rd and 5th day. The 
percentage transmittance was recorded in similar way. 
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THERMAL-50ºC: 
Bulk preparation (stress) 
The next day, the bulk from chamber was removed and the required quantity has been 
taken from the petri dish. It was kept in the same place. The required amount bulk drug 
was reground with dry KBr agate mortar and pestle .The discs were prepared by using 
KBr press instrument. Then the percentage transmittance of the bulk drug was measured. 
The same procedure was repeated for 3rd and 5th day. The percentage transmittance was 
recorded in similar way. 
Sample preparation (stress) 
Similar bulk procedure was followed. 
SUNLIGHT: 
Bulk preparation (stress) 
The next day (1st) day, the required quantity has been taken from the petri dish. It was 
kept in the same place .The required amount of bulk was reground with dry KBr to using 
agate mortar and pestle. The discs were prepared by using KBr press instrument .Then 
the percentage transmittance of the bulk was measured .Compared the spectrum with 
standard spectrum. The same procedure was repeated for 3rd and 5th day. The percentage 
transmittance was recorded in similar way. 
Sample preparation (stress) 
 Similar bulk procedure was followed. 
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3. RP-HIGH PERFORMANCE LIQUID CHROMATOGRAPHY: 
High Performance Liquid Chromatography: 
High Performance Liquid Chromatography (HPLC) is a form of liquid chromatography 
to separate compounds that are dissolved in solution. This technique is based on the 
modes of separation like adsorption, partition, including reverse phase partition, ion–
exchange and gel permeation. HPLC instrument consists of a reservoir of mobile phase, a 
pump, an injector, a separation column, and a detector; Compounds are separated by 
injecting a plug of the sample mixture onto the column. The different compounds in the 
mixture pass through the column at different rates due to differences in their partitioning 
behavior between the mobile liquid phase and the stationary phase. 
Intraday scheme HPLC-study of Bulk & Formulation (Table: 4) 
 
 
 
     
   
DEGRADATION 
EXPERIMENTAL 
CONDITIONS 
STORAGE 
CONDITION 
SAMPLING 
TIME 
 
Control Sample 
(No acid or base) 
Room temperature 90mins 
Hydrolysis 
0.1N HCL Room temperature 90mins 
0.1N NaOH Room temperature 90mins 
Acid Control (no API) Room temperature 90mins 
Base Control (no API) Room temperature 90mins 
Oxidative 
30%H2O2 Room temperature 90mins 
30%H2O2(no API) Room temperature 90mins 
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  Interday scheme HPLC-study of Bulk & Formulation (Table: 5) 
 
 
REAGENTS AND CHEMICALS USED FOR HPLC: 
 Methanol  
 Distilled water 
 
Preparation of mobile phase: 
Mobile phase was prepared with 60 % of methanol and 40% of distilled water (60:40) 
respectively. The mobile phase should be prepared freshly, filtered through a 0.45µm 
membrane filter and sonicated before use. 
Standard preparation: 
Cefuroxime axetil was transferred to volumetric flask and dissolved in methanol to 
achieve a concentration of 1mgmL-1 .An aliquot solution was diluted with distilled water 
to get a final concentration of 10µg/mL. 
DEGRADATION 
EXPERIMENTAL 
CONDITIONS 
STORAGE 
CONDITION 
SAMPLING 
TIME 
 
Control Sample 
(No acid or base) 
Room temperature 3rd day 
Hydrolysis 
0.1N HCl Room temperature 3rd day 
0.1N NaOH Room temperature 3rd day 
Acid Control (no API) Room temperature 3rd day 
Base Control (no API) Room temperature 3rd day 
Oxidative 
30%H2O2 Room temperature 3rd day 
30%H2O2(no API) Room temperature 3rd day 
Thermal Heating chamber 50ºC 3rd day 
Photolysis Powder form Sun Light 3rd day 
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Bulk preparation (stress) 
50mg of Cefuroxime axetil was weighed, transferred to volumetric flask and dissolved in 
distilled water to achieve a concentration of 1mg/mL. An aliquot solution was diluted 
with water to get a final concentration of 10µg/mL. 
Sample preparation (stress) 
50mg equivalent of Cefuroxime axetil tablets were weighed transferred to volumetric 
flask and dissolved in distilled water to achieve a concentration of 1mg/mL. An aliquot 
solution was diluted with water to get a final concentration of 10µg/mL. Before the 
sample, bulk and standard solutions were filtered through a 0.45µm membrane filter. 
Chromatographic conditions: 
Column              : C 18 (Reversed Phase) 
Stationary Phase:  Silica 
Elution type       :  Isocratic 
Mobile phase     : Methanol: Water (6:4)     
Detector             : PDA detector 
Flow rate           : 1 mL/min. 
 
Determination of Retention Time: 
The mobile phase was injected first to determine the absence of any interference with the 
base line. The retention time was then determined by injecting 20 µL of the standard in 
the column and the retention time was determined using 278 nm as the detection 
wavelength. The retention time was found to be 9.2 and 10.3mins for Cefuroxime axetil. 
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Analysis of sample solution: 
The sample solution was diluted to get the required concentration and used for the 
estimation of Cefuroxime axetil. 20 µL of the solution was injected into the column, 
retention time and peak area was determined. 
Assay: 
20 µL of standard and sample solutions were injected separately with the flow rate of 
1mL/minute of the mobile phase containing Methanol and Distilled water of (6:4) 
proportion. The amount of Cefuroxime axetil was calculated from the obtained 
chromatogram. 
 

	 =
.	 × .	 × . 
	 × .	 × 	
	
. 	 × .	 × 
 
 
Percentage content of Cefuroxime axetil 
 
	
 =

	
	
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3.1 INTRADAY STUDY BY HPLC OF BULK AND FORMULATION 
Hydrolytic Degradation Using 0.1N NaOH 
Standard preparation  
50mg of Cefuroxime axetil was weighed and transferred to 50mL volumetric flask. It was 
dissolved in methanol and the volume made up to 50mL to achieve a concentration of 
1mg/mL. An aliquot solution was diluted with distilled water to get a final concentration 
of 10µg/mL. 
Bulk preparation (stress) 
50mg of Cefuroxime axetil was weighed and transferred to a 50mL volumetric flask. It 
was dissolved in 0.1N NaOH and the volume made up to 50mL to achieve a 
concentration of 1mg/mL. After 90mins, an aliquot solution was diluted with mobile 
phase to get a concentration of 10µg/mL. The retention time and peak area were 
determined by recording the chromatograms. 
Sample preparation (stress) 
50mg equivalent of Cefuroxime axetil tablets were weighed and transferred to a 50mL 
volumetric flask. It was dissolved in 0.1N NaOH and the volume made up to 50mL to 
achieve a concentration of 1mg/mL. After 90mins, an aliquot solution was diluted with 
mobile phase to get a concentration of 10µg/mL. The retention time and peak area were 
determined by recording the chromatograms. 
Blank preparation 
50mL of 0.1N NaOH was taken in a 50mL volumetric flask. After 90mins, as before 
solution was injected in to the column. 
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HYDROLYTIC DEGRADATION USING 0.1N HCl 
Bulk preparation (stress) 
50mg of Cefuroxime axetil was weighed and transferred to a 50mL volumetric flask. It 
was dissolved in methanol and the volume made up to 50mL using 0.1N HCl to achieve a 
concentration of 1mg/mL. After 90mins, an aliquot solution was diluted with mobile 
phase to get a concentration of 10µg/mL. The retention time and peak area were 
determined by recording the chromatograms. 
Sample preparation (stress) 
50mg equivalent of Cefuroxime axetil tablets were weighed and transferred to a 50mL 
volumetric flask. It was dissolved in methanol and the volume made up to 50mL 
using0.1N HCl to achieve a concentration of 1mg/mL. After 90mins, an aliquot solution 
was diluted with mobile phase to get a concentration of 10µg/mL. The retention time and 
peak area were determined by recording the chromatograms. 
Blank preparation 
50mL of 0.1N HCl was taken in a 50mL volumetric flask. After 90mins, as before 
solution was injected in to the column. 
OXIDATIVE DEGRADATION USING 30% H2O2 
Bulk preparation (stress) 
50mg of Cefuroxime axetil was weighed and transferred to a 50mL volumetric flask. It 
was dissolved in methanol and the volume made up to 50mL using 30% H2O2 to achieve 
a concentration of 1mg/mL. After 90mins, an aliquot solution was diluted with mobile 
phase to get a concentration of 10µg/mL. The retention time and peak area were 
determined by recording the chromatograms. 
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Sample preparation (stress) 
50mg equivalent of Cefuroxime axetil tablets were weighed and transferred to a 50mL 
volumetric flask. It was dissolved in methanol and the volume made up to 50mL using 
30% H2O2 to achieve a concentration of 1mg/mL. After 90mins, an aliquot solution was 
diluted with mobile phase to get a concentration of 10µg/mL. The retention time and 
peak area were determined by recording the chromatograms. 
Blank preparation 
50mL of 30% H2O2 was taken in a 50mL volumetric flask. After 90mins, as before 
solution was injected in to the column. 
3.2 INTERDAY STUDY BY HPLC OF BULK AND FORMULATION 
Hydrolytic Degradation Using 0.1N NaOH 
Standard preparation  
50mg of Cefuroxime axetil was weighed and transferred to 50mL volumetric flask. It was 
dissolved in methanol and the volume made up to 50mL to achieve a concentration of 
1mg/mL. An aliquot solution was diluted with distilled water to get a final concentration 
of 10µg/mL. Standard should be prepared daily. 
Bulk preparation (stress) 
50mg of Cefuroxime axetil was weighed and transferred to a 50mL volumetric flask. It 
was dissolved in 0.1N NaOH and the volume made up to 50mL to achieve a 
concentration of 1mg/mL. Then the third day, an aliquot solution was diluted with mobile 
phase to get a concentration of 10µg/mL. The retention time and peak area were 
determined by recording the chromatograms. 
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Sample preparation (stress) 
50mg equivalent of Cefuroxime axetil tablets were weighed and transferred to a 50mL 
volumetric flask. It was dissolved in 0.1N NaOH and the volume made up to 50mL to 
achieve a concentration of 1mg/mL. The third day, an aliquot solution was diluted with 
mobile phase to get a concentration of 10µg/mL. The retention time and peak area were 
determined by recording the chromatograms. 
Blank preparation 
50mL of 0.1N NaOH was taken in a 50mL volumetric flask. An aliquot solution was 
diluted with distilled water to get a final concentration. The blank solution was injected in 
to the column. 
HYDROLYTIC DEGRADATION USING 0.1N HCl 
Bulk preparation (stress) 
50mg of Cefuroxime axetil was weighed and transferred to a 50mL volumetric flask. It 
was dissolved in methanol and the volume made up to 50mL using 0.1N HCl to achieve a 
concentration of 1mg/mL. The third day, an aliquot solution was diluted with mobile 
phase to get a concentration of 10µg/mL. The retention time and peak area were 
determined by recording the chromatograms. 
Sample preparation (stress) 
50mg equivalent of Cefuroxime axetil tablets were weighed and transferred to a 50mL 
volumetric flask. It was dissolved in methanol and the volume made up to 50mL using 
0.1N HCl to achieve a concentration of 1mg/mL. The third day, an aliquot solution was 
diluted with mobile phase to get a concentration of 10µg/mL. The retention time and 
peak area were determined by recording the chromatograms. 
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Blank preparation 
50mL of 0.1N HCl was taken in a 50mL volumetric flask. An aliquot solution was 
diluted with distilled water to get a final concentration. The blank solution was injected in 
to the column. 
OXIDATIVE DEGRADATION USING 30% H2O2 
Bulk preparation (stress) 
50mg of Cefuroxime axetil was weighed and transferred to a 50mL volumetric flask. It 
was dissolved in methanol and the volume made up to 50mL using 30% H2O2 to achieve 
a concentration of 1mg/mL. The third day, an aliquot solution was diluted with mobile 
phase to get a concentration of 10µg/mL. The retention time and peak area were 
determined by recording the chromatograms. 
Sample preparation (stress) 
50mg equivalent of Cefuroxime axetil tablets were weighed and transferred to a 50mL 
volumetric flask. It was dissolved in methanol and the volume made up to 50mL using 
30% H2O2 to achieve a concentration of 1mg/mL. The third day, an aliquot solution was 
diluted with mobile phase to get a concentration of 10µg/mL. The retention time and 
peak area were determined by recording the chromatograms. 
Blank preparation 
50mL of 30% H2O2 was taken in a 50mL volumetric flask. The third day, an aliquot 
solution was diluted with distilled water to get a final concentration. The blank solution 
was injected in to the column. 
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THERMAL DEGRADATION AT 50ºC 
Bulk preparation (stress) 
1g of Cefuroxime axetil bulk was weighed and transferred to a petri dish. This petri dish 
was placed in a hot air over at the temperature of 50ºC. The third day, 50mg Cefuroxime 
axetil bulk was weighed from a petri dish and transferred to 50mL volumetric flask. It 
was dissolved in mobile phase and the volume made up to 50mL. An aliquot solution was 
diluted with mobile phase to get a final concentration of 10µg/mL.  
Sample preparation (stress) 
1g of Cefuroxime axetil tablets were crushed weighed and transferred to a petri dish. This 
petri dish was placed in a hot air over at the temperature of 50ºC. The third day, 50mg 
equivalent of Cefuroxime axetil tablet was weighed from a petri dish and transferred to 
50mL volumetric flask. It was dissolved in ethanol and the volume made up to 50mL. An 
aliquot solution was diluted with mobile phase to get a final concentration of 10µg/mL. 
PHOTOLYTIC DEGRADATION USING SUN LIGHT 
Bulk preparation (stress) 
1g of Cefuroxime axetil bulk was weighed and transferred to a petri dish. This petri dish 
was placed under a sun light. The third day, 50mg Cefuroxime axetil bulk was weighed 
from a petri dish and transferred to 50mL volumetric flask. It was dissolved in ethanol 
and the volume made up to 50mL. An aliquot solution was diluted with mobile phase to 
get a final concentration of 10µg/mL.  
Sample preparation (stress) 
1g of Cefuroxime axetil tablets were crushed weighed and transferred to a petri dish. This 
petri dish was placed under a sun light. The third day, 50mg equivalent of Cefuroxime 
axetil was taken from the petri dish and transferred to 50mL volumetric flask. It was 
dissolved in ethanol and the volume made up to 50mL. An aliquot solution was diluted 
with mobile phase to get a final concentration of 10µg/mL.  
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4. THIN LAYER CHROMATOGRAPHY 
 
TLC is used for identification of degradation whether the drug is degraded or not. 
Presence of impurities and no of impurities were detected by no of spots were shown 
after the detection. Various mobile phases given below have been tried for Cefuroxime 
axetil.  
 
 Hexane: Ethyl acetate (6:4) 
 Chloroform: Toluene: Methanol (6:2:2) 
 Chloroform: Methanol: Water (6:2:2) 
 Chloroform: Methanol (5:5) 
 Chloroform: Ethanol (9:1) 
 
Mobile phase containing Chloroform and Ethanol (9:1) were chosen for the study as it 
gave better resolution. Detection was carried out at by using UV chamber at λ max 
366nm. 
 
Rf value was calculated by following formula. 
 
 ! =
"#$%&'()	%*&+),,)-	./	$0,1%)
"#$%&'()	%*&+),,)-	./	$0,+)'%
 
 
Mobile phase preparation 
Mobile phase was prepared by using chloroform and ethanol in the ratio of 9:1. Then the 
mobile phase was allowed for saturation. Mobile phase should be prepared freshly. 
Detection was done by UV chamber at λ max 366nm. 
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Intraday TLC study of Bulk & Formulation (Table: 6) 
 
Interday TLC study of bulk & formulation (Table: 7) 
 
 
 
DEGRADATION 
EXPERIMENTAL 
CONDITIONS 
STORAGE 
CONDITION 
SAMPLING TIME 
 
Control Sample 
(No acid or base) 
Room temperature 90mins 
Hydrolysis 
 
0.1N HCL Room temperature 90mins 
0.1N NaOH Room temperature 90mins 
Acid Control (no API) Room temperature 90mins 
Base Control (no API) Room temperature 90mins 
Oxidative 
30%H2O2 Room temperature 90mins 
30%H2O2(no API) Room temperature 90mins 
DEGRADATION EXPERIMENTAL CONDITIONS 
STORAGE 
CONDITION SAMPLING TIME 
 
Control Sample 
(No acid or base) Room temperature 3rd day 
Hydrolysis 
 
0.1N HCL Room temperature 3rd day 
0.1N NaOH Room temperature 3rd day 
Acid Control (no API) Room temperature 3rd day 
Base Control (no API) Room temperature 3rd day 
Oxidative 
 
30%H2O2 Room temperature 3rd day 
30%H2O2(no API) Room temperature 3rd day 
Thermal Heating chamber 50ºC 3rd day 
Photolysis Powder form Sunlight 3rd day 
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1. INTRADAY HYDROLYTIC DEGRADATION USING 0.1N NaOH 
Preparation of standard  
10mg of Cefuroxime axetil was dissolved in 10mL of methanol and used as a standard. 
Standard should be prepared freshly.  
 
Detecting chamber: UV chamber 
 
Bulk preparation (stress)  
50mg of Cefuroxime axetil was transferred to volumetric flask and dissolved in 0.1N 
Sodium hydroxide to achieve a concentration of 1mg/mL. The solution was kept at room 
temperature.  After 90mins, the sample was spotted on the TLC plate using micropipette. 
This was marked as D. Then standard was applied and denoted as P. Then the TLC was 
placed in the mobile phase containing TLC chamber for elution. After sufficient elution 
TLC plate was removed from the TLC chamber and placed in an UV chamber for 
detection. 
Sample preparation (stress) 
50mg equivalent of Cefuroxime axetil tablets were weighed and transferred to volumetric 
flask. It was dissolved in 0.1N sodium hydroxide was added to achieve a concentration of 
1mg/mL. The solution was kept at room temperature. After 90mins, the sample was 
spotted on the TLC plate using micropipette. This was marked as D. Then standard was 
applied and denoted as P. Then the TLC was placed in the TLC chamber containing 
mobile phase for elution. After sufficient elution TLC plate was removed from the TLC 
chamber and placed in an UV chamber for detection.  
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HYDROLYTIC DEGRADATION USING 0.1N HCl 
Bulk preparation (stress) 
50mg of Cefuroxime axetil was transferred to volumetric flask and dissolved in 0.1N 
Hydrochloric acid to achieve a concentration of 1mg/mL. The solution was kept at room 
temperature.  After 90mins, the sample was spotted on the TLC plate using micropipette. 
This was marked as P. Then standard was applied and denoted as D. Then the TLC was 
placed in the mobile phase containing TLC chamber for elution. After sufficient elution 
TLC plate was removed from the TLC chamber and placed in an UV chamber for 
detection. 
Sample preparation (stress) 
50mg equivalent of Cefuroxime axetil tablets were weighed and transferred to volumetric 
flask; dissolved in 0.1N Hydrochloric acid was added to achieve a concentration of 
1mg/mL. The solution was kept at room temperature. After 90mins, the sample was 
spotted on the TLC plate using micropipette. This was noted as D. Then standard was 
applied and denoted as P. Then the TLC was placed in the TLC chamber containing 
mobile phase for elution. After sufficient elution TLC plate was removed from the TLC 
chamber and placed in an UV chamber for detection. 
OXIDATIVE DEGRADATION USING 30%H2O2 
Bulk preparation (stress) 
50mg of Cefuroxime axetil was weighed and transferred to volumetric flask and 
dissolved in 30% Hydrogen peroxide to achieve a concentration of 1mg/mL. The solution 
was kept at room temperature. After 90mins, the sample was spotted on the TLC plate 
using micropipette. This was marked as D. Then standard was applied and denoted as P.  
Then the TLC was placed in the TLC chamber containing mobile phase for elution. After 
the sufficient elution TLC plate was removed from the TLC chamber and placed in an 
UV chamber for detection. 
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Sample preparation (stress) 
50mg equivalent of Cefuroxime axetil tablets were crushed weighed and transferred to 
volumetric flask dissolved in 30%Hydrogen peroxide to achieve a concentration of 
1mg/mL. The solution was kept at room temperature. After 90mins, the sample was 
spotted on the TLC plate using micropipette. This was marked as D. Then standard was 
applied and denoted as P. Then the TLC was placed in the TLC chamber containing 
mobile phase for elution. After the sufficient elution TLC plate was removed from the 
TLC chamber and placed in an UV chamber for detection. 
 
4.2.INTERDAY  DEGRADATION USING 0.1N NaOH, 0.1N HCl AND 30% H2O2 
Same procedure was adopted as intraday procedure. After three days exposure samples 
were collected. 
THERMAL DEGRADATION AT 50ºC 
Bulk preparation (stress) 
1g of Cefuroxime axetil bulk was weighed and transferred to a petri dish. This petri dish 
was placed in a hot air over at the temperature of 50ºC. The third day, the sample was 
spotted on the TLC plate using micropipette. This was noted as D. Then standard was 
applied and marked as P. Then the TLC was placed in the TLC chamber containing 
mobile phase for elution. After sufficient elution TLC plate was removed from the TLC 
chamber and placed in an UV chamber for detection.     
Sample preparation (stress) 
1g of Cefuroxime axetil tablets were weighed and transferred to a petri dish. This petri 
dish was placed in a hot air over at the temperature of 50ºC. The third day, the sample 
was spotted on the TLC plate using micropipette. This was marked as D. Then standard 
was applied and denoted as P. Then the TLC was placed in the TLC chamber containing 
mobile phase for elution. After sufficient elution TLC plate was removed from the TLC 
chamber and placed in an UV chamber for detection.     
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PHOTOLYTIC DEGRADATION USING SUN LIGHT 
Bulk preparation (stress) 
1g of Cefuroxime axetil bulk was weighed and transferred to a petri dish. This petri dish 
was placed under a sun light. The third day, the sample was spotted on the TLC plate 
using micropipette. This was marked as D. Then standard was applied and denoted as P. 
Then the TLC was placed in the TLC chamber containing mobile phase for elution. After 
sufficient elution TLC plate was removed from the TLC chamber and placed in an UV 
chamber for detection.    .  
Sample preparation (stress) 
1g of Cefuroxime axetil tablets were weighed and transferred to a petri dish. This petri 
dish was placed under a sun light. The third day, the sample was spotted on the TLC plate 
using micropipette. This was marked as D. Then standard was applied and denoted as P. 
Then the TLC was placed in the TLC chamber containing mobile phase for elution. After 
sufficient elution TLC plate was removed from the TLC chamber and placed in an UV 
chamber for detection.     
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RESULTS AND DISCUSSION 
 
1. Hydrolytic Degradation Study Using 0.1N Sodium hydroxide 
 
Hydrolytic degradation study was carried out as per the procedure given in the 
material and methods. The assay value of active ingredients was calculated using UV 
spectrophotometry. The respective UV spectrum and the values are given in Fig.1-4 
and Table: 8, 9. 
 Fig.1 Overlay spectrum of Cefuroxime axetil Bulk with Standard in 0.1N NaOH     
                                       30mins                            90mins 
  
Fig.2 Overlay spectrum of Cefuroxime axetil Sample with Standard in 0.1N NaOH    
     30mins           60mins 
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Fig.3 Overlay spectrum of Cefuroxime axetil Bulk with Standard in 0.1N NaOH 
                            1st day                                                                5th day 
            
 
Fig.4 Overlay spectrum of Cefuroxime axetil Sample with Standard in 0.1N NaOH 
 
                             1st day                                                                5th day                 
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Table: 8 Intraday results of Hydrolytic Degradation Using 0.1 N NaOH 
 
S.No. 
 
Drug Absorbance Standard Time 
1 Bulk 0.331 0.399 30mins 
2  0.345   
3  0.338   
1 Sample 0.360   
2  0.354   
3  0.366   
1 Bulk 0.350 0.397 60mins 
2  0.345   
3  0.355   
1 Sample 0.332   
2  0.329   
3  0.325   
1 Bulk 0.256 0.398 90mins 
2  0.252   
3  0.260   
1 Sample 0.326   
2  0.331   
3  0.321   
 
Table.8.1: Results Obtained From Hydrolytic Degradation0.1 N NaOH 
Stress condition 
(Alkali Hydrolysis) Time 
Bulk Percentage 
Content (%) 
Sample percentage 
Content (%) 
0.1 N Sodium 
Hydroxide 
30mins 84.9 90.5 
60mins 78.1 83.2 
90mins 64.3 81.9 
 
 Each value is the mean of three determinations. 
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Table: 9 Interday Result of Hydrolytic Degradation Using 0.1 N NaOH:  
 
S.No. 
 
Drug Absorbance Standard Time 
1 Bulk 0.066 0.395 1stday 
2  0.080   
3  0.072   
1 Sample 0.100   
2  0.093   
3  0.097   
 
 
Table.9.1: Results Obtained From Hydrolytic Degradation - 0.1 N NaOH 
Stress condition 
(Alkali 
hydrolysis) 
Time Bulk Percentage Content (%) 
Sample percentage 
Content (%) 
0.1 N Sodium 
Hydroxide 
1stday 18.0 24.4 
3rdday 0 0 
5stday 0 0 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                                                        RESULTS AND DISCUSSION 
 
 
GRAPHICAL REPRESENTATION OF INTRADAY AND INTERDAY STUDY  
 
Fig.5 Assay values of Bulk and Sample at Various Time Intervals 
 
 
Fig.6 Assay values of Bulk and Sample at Various Time intervals 
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The study results indicated that Cefuroxime axetil was unstable under alkali hydrolysis 
condition; the Table: 8 show the results of intraday degradation and remaining assay 
values of standard and sample. In intraday degradation drug standard and sample showed 
extensive degradation. Compared to sample, standard had undergone more degradation. 
The assay values of standard and sample were 64.3% and 81.9% respectively at end of 
the 90mins degradation. The table: 9 shows that the results of interday degradation. In 
inter-day degradation study on 1st day standard and sample have undergone maximum 
degradation. . The assay values of standard and sample were found to be 18.0% and 
24.4% respectively. Complete degradation was observed 3rd day onwards. 
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HYDROLYTIC DEGRADATION USING 0.1N HYDROCHLORIC ACID 
Hydrolytic degradation study was carried out as per the procedure given in the material 
and methods. The assay value of active ingredients was calculated using UV 
spectrophotometry. The respective UV spectrum and the values are given in Fig.7-10 
and Table: 10, 11. 
Fig.7 Overlay spectrum of Cefuroxime axetil Bulk with Standard in 0.1N HCl 
                   30mins                                                          90mins 
               
 
Fig.8 Overlay spectrum of Cefuroxime axetil Sample with Standard in 0.1N HCl 
 
                                30mins              90mins 
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Fig. 9 Overlay spectrum of Cefuroxime axetil Bulk with Standard in 0.1N HCl 
                           1st day                                                           5th day 
          
 
 
Fig. 10 Overlay spectrum of Cefuroxime axetil Sample with Standard in 0.1N HCl 
                         1st day                                                                5th day 
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 Table 10: Absorbance Values for Hydrolytic Degradation Using 0.1 N HCl 
 
S.No. 
 
Drug Absorbance Standard Time 
1 Bulk 0.355 0.398 30mins 
2  0.350   
3  0.360   
1 Sample 0.372   
2  0.378   
3  0.366   
1 Bulk 0.334 0.396 60mins 
2  0.339   
3  0.329   
1 Sample 0.334   
2  0.336   
3  0.332   
1 Bulk 0.302 0.397 90mins 
2  0.298   
3  0.306   
1 Sample 0.310   
2  0.319   
3  0.301   
 
Table.10.1: Results Obtained from Hydrolytic Degradation 0.1 N HCl 
Stress condition 
Acid Hydrolysis Time 
Bulk Percentage 
Content (%) 
Sample percentage 
Content (%) 
0.1 N Hydrochloric 
acid 
30mins 89.2 93.4 
60mins 83.9 84.9 
90mins 75.8 78.1 
 
 
 Each value is the mean of three determinations. 
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Table: 11 Absorbance Values for Hydrolytic Degradation Using - 0.1 N HCl 
 
 
 
 
 
 
 
      Each value is the mean of three determinations 
 
Table.11.1: Results Obtained From Hydrolytic Degradation - 0.1 N HCl 
Stress condition 
(Alkali hydrolysis) Time 
Bulk Percentage 
Content (%) 
Sample percentage 
Content (%) 
0.1 N Hydrochloric acid 
1stday 0 0 
3rdday 0 0 
5thday 0 0 
 
 
 
 
 
 
 
 
 
 
 
S.No. 
 
Drug Absorbance Standard Time 
1 Bulk 0 0 1stday 
2  0 0  
3  0 0  
1 Sample 0 0  
2  0 0  
3  0 0  
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GRAPHICAL REPRESENTATION OF INTRADAY AND INTERDAY STUDY  
Fig. 11 Assay values of Bulk and Sample at Various Time Intervals 
 
 
Hydrolytic acid degradation indicated that Cefuroxime axetil was unstable under acid 
hydrolysis condition. In intraday degradation standard drug and sample showed small 
amount of degradation. Compared to sample, standard underwent more degradation. The 
assay values of standard and sample were 75.8% and 78.1% respectively at the end of 
90mins degradation. In inter-day degradation study complete degradation was observed 
on both standard and sample by the end of the first day.    
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OXIDATIVE DEGRADATION USING 30% HYDROGEN PEROXIDE 
Oxidative degradation study was carried out as per the procedure given in the material 
and methods. The assay value of active ingredients was calculated using UV 
spectrophotometry. The respective UV spectrum and the values are given in Fig.12-15 
and Table: 12, 13. 
Fig.12 Overlay spectrum of Cefuroxime axetil Bulk with Standard in 30% H2O2 
                                    30mins            90mins 
 
Fig.13 Overlay spectrum of Cefuroxime axetil Sample with Standard in 30% H2O2 
                                     30mins               90mins 
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Fig. 14 Overlay spectrum of Cefuroxime axetil Bulk with Standard in 30% H2O2 
                                 1st day                                                            5th day 
              
 
 
Fig. 15 Overlay spectrum of Cefuroxime axetil Sample with Standard in 30% H2O2 
                             1st day                                                                5th day 
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Table: 12 Absorbance Values for Oxidative Degradation Using 30% H2O2 
 
S.No. 
 
Drug Absorbance Standard Time 
1 Bulk 0.332 0.398 30mins 
2  0.340   
3  0.324   
1 Sample 0.358   
2  0.351   
3  0.365   
1 Bulk 0.305 0.398 60mins 
2  0.309   
3  0.301   
1 Sample 0.328   
2  0.333   
3  0.323   
1 Bulk 0.251 0.400 90mins 
2  0.250   
3  0.252   
1 Sample 0.306   
2  0.302   
3  0.310   
 
Table.12.1: Results Obtained from Oxidative Degradation - 30% H2O2 
Stress condition 
(Oxidation) Time 
Bulk Percentage 
Content (%) 
Sample percentage 
Content (%) 
30% H2O2 
30mins 83.3 89.9 
60mins 76.6 82.5 
90mins 63.1 76.8 
 
 Each value is the mean of three determinations. 
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  Table 13: Absorbance Values For Oxidative Degradation Using - 30% H2O2 
 
S.No. 
 
Drug Absorbance Standard Time 
1 Bulk 0.230 0.395 1stday 
2  0.216   
3  0.223   
1 Sample 0.250   
2  0.232   
3  0.241   
 
  Table.13.1: Results Obtained From Oxidative Degradation - 30% H2O2 
Stress condition 
(Oxidation) Time 
Bulk Percentage 
Content (%) 
Sample 
percentage 
Content (%) 
30% H2O2 
1stday 56.1 60.6 
3rdday 0 0 
5thday 0 0 
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GRAPHICAL REPRESENTATION OF OXIDATIVE DEGRADATION STUDY  
 
Fig.16 Assay values of Bulk and Sample at Various Time Intervals 
 
 
Fig.17 Assay values of Bulk and Sample at Various Time Intervals 
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 Oxidative degradation shows that Cefuroxime axetil was found to be unstable under 
oxidative condition. Extensive degradation was observed on both standard and sample in 
intraday and 2nd day onwards. Compared to sample, standard underwent more 
degradation. The assay values of standard and sample were 63.1% and 73.8% 
respectively at the end of 90mins degradation. \ 
In inter-day degradation study, on 1st day standard and sample have undergone maximum 
degradation. . The assay values of standard and sample were 56.1% and 60.6% 
respectively. Complete degradation was seen from 3rd day onwards.  
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THERMAL DEGRADATION 
Cefuroxime axetil standard and sample were kept in heating chamber at 50 ͦC. The 
standard and sample powders were collected at different time intervals and the assay 
values were calculated by UV spectroscopy. The respective UV spectrum and the values 
are given in Fig.18, 19 Table-14. 
  
Fig. 18 Overlay spectrum of Cefuroxime axetil Bulk with Standard  
                             1st day                                                                5th day 
              
Fig. 19 Overlay spectrum of Cefuroxime axetil Sample with Standard  
                             1st day                                                                5th day 
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Table 14: Absorbance Values for Thermal at 50ºC 
 
S.No. 
 
Drug Absorbance Standard Time 
1 Bulk 0.382 0.392 1stday 
2  0.385   
3  0.379   
1 Sample 0.388   
2  0.391   
3  0.385   
1 Bulk 0.351 0.398 3rdday 
2  0.340   
3  0.362   
1 Sample 0.365   
2  0.349   
3  0.333   
1 Bulk 0.330 0.399 5thday 
2  0.340   
3  0.335   
1 Sample 0.325   
2  0.332   
3  0.318   
 
Table.14.1: Results Obtained from Thermal Degradation – 50ºͦC 
Stress condition 
(Thermal) Time 
Bulk Percentage 
Content (%) 
Sample percentage 
Content (%) 
50ºC 
1stday 96.0 91.5 
3rdday 88.2 87.7 
5thday 82.9 81.7 
• Each value is the mean of three determinations. 
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GRAPHICAL REPRESENTATION OF THERMAL DEGRADATION STUDY  
Fig.20 Assay values of Bulk and Sample at Various Time Intervals 
 
 
In Thermal degradation only small amount of degradation was observed up to 5th day. 
It shows that bulk and formulation exhibit stability against temperature. At the end of the 
5th day the assay value bulk and sample were found to be 82.9 and 81.7 respectively. 
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PHOTOLYTIC DEGRADATION USING SUNLIGHT 
Cefuroxime axetil standard and sample were kept in heating chamber at 50ºC. The 
standard and sample powders were collected at different time intervals and the assay 
values were calculated by UV spectroscopy. The respective UV spectrum and the values 
are given in Fig.21, 22 Table-15. 
 
Fig. 21 Overlay spectrum of Cefuroxime axetil Bulk with Standard  
                                 1st day                                                                5th day 
               
Fig. 22 Overlay spectrum of Cefuroxime axetil Sample with Standard  
                                 1st day                                                                5th day 
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    Table 15: Absorbance Values for Photolytic Degradation Using Sunlight 
 
S.No. 
 
Drug Absorbance Standard Time 
1 Bulk 0.380 0.399 1stday 
2  0.392   
3  0.398   
1 Sample 0.388   
2  0.394   
3  0.382   
1 Bulk 0.363 0.397 3rdday 
2  0.371   
3  0.355   
1 Sample 0.340   
2  0.349   
3  0.331   
1 Bulk 0.342 0.399 5thday 
2  0.352   
3  0.332   
1 Sample 0.315  
 
2  0.324   
3  0.306   
 
Table.15.1: Results Obtained from Photolytic Degradation – Sunlight 
Stress condition 
(photolytic) Time 
Bulk Percentage 
Content (%) 
Sample percentage 
Content (%) 
Sunlight 
 
1stday 95.5 97.5 
3rdday 91.2 85.4 
5thday 85.9 79.1 
• Each value is the mean of three determinations. 
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GRAPHICAL REPRESENTATION OF PHOTOLYTIC DEGRADATION STUDY  
Fig.23 Assay values of Bulk and Sample at Various Time Intervals 
 
 
In Photolytic degradation studies show that sample was undergone more amount of 
degradation compared to bulk. The assay values of standard and sample were found to be 
85.9% and 79.1% at the end of 5th day degradation.  
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2) IR STUDY OF BULK&SAMPLE-UNDER STRESS &NORMAL CONDITION: 
In interday Thermal and photolytic degradation the samples were kept in heating chamber 
and sunlight. The next day the samples were taken and ground with KBr. Then the KBr 
pellets were formed using pellet pressing technique. IR spectrum was taken for pellets. IR 
spectrum is given in Fig.24-31, Table-16. 
THERMAL DEGRADATION 
 Fig.24 Overlay IR Spectrum of Standard with Bulk in 1st Day 
 
Fig. 25 Overlay IR Spectrum of Standard with Bulk in 5th Day 
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Fig. 26 Overlay IR Spectrum of Standard with Sample in 1st Day 
 
Fig. 27 Overlay IR Spectrum of Standard with Sample in 5th Day 
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PHOTOLYTIC DEGRADATION USING SUNLIGHT 
Fig. 28 Overlay IR Spectrum of Standard with Bulk in 1st Day 
 
 
Fig. 29 Overlay IR Spectrum of Standard with Bulk in 5th Day 
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Fig. 30 Overlay IR Spectrum of Standard with Sample in 1st Day 
 
 
Fig. 31 Overlay IR Spectrum of Standard with Sample in 1st Day 
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Table: 16 IR STUDY OF THERMAL & PHTOLYTIC DEGRADATION  
 
Band Frequency 
(cm-1) Bulk Sample Result 
3478 N-H Stretching 
 
N-H Stretching 
 
No changes 
observed 
3001 C-H Stretching C-H Stretching No changes 
observed 
1735 C=O Stretching C=O Stretching No changes 
observed 
1681 C=N Stretching C=N Stretching No changes 
observed 
1596 C=C Stretching C=C Stretching No changes 
observed 
 
 
It was observed that the standard and sample were less susceptible to Photolytic 
degradation during the interday study. The assay value was found to be around 80% at 
the end of 5th day. The degraded samples were subjected to IR study where no structural 
changes were observed in Thermal and Photolytic degradation. 
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3) RP-HPLC STUDY OF BULK&SAMPLE-UNDER STRESS CONDITIONS 
 
In RP-HPLC C-18 silica column was found to be suitable for Cefuroxime axetil. The 
mobile phase used for assay was methanol and water in the ratio of 6:4. The flow rate 
maintained was 1mL/min. The PDA detector was used in the wavelength of 280nm. The 
retention time was found to be 9.5 and 10.6. The standard chromatogram is given in 
Fig.32. 
 
Fig.32 STANDARD CHROMATOGRAM 
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INTRADAY RP-HPLC STUDY 
The chromatograms for intraday study are given in Fig.33-38 and Table-17. 
Fig.33 Chromatogram for Cefuroxime axetil Bulk in 0.1N NaOH (90mins) 
 
 
Fig.34 Chromatogram for Cefuroxime axetil Sample in 0.1N NaOH (90mins) 
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Fig.35 Chromatogram for Cefuroxime axetil Bulk in 0.1N HCl (90mins) 
 
 
 
Fig.36 Chromatogram for Cefuroxime axetil Sample in 0.1N HCl (90mins)  
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Fig.37 Chromatogram for Cefuroxime axetil Bulk in 30% H2O2 (90mins) 
 
 
 
 
Fig.38 Chromatogram for Cefuroxime axetil Sample in 30% H2O2 (90mins) 
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Table: 17 Intraday Study for Degradation  
Stress condition 
 
Time Bulk Peak Area Sample Peak Area 
0.1N NaOH(Alkali) 90mins  942.5 
 
1080.0 
 
0.1N HCl(Acid) 90mins 
 
1050.2 
 
1080.4 
 
30% H2O2(Oxidation) 90mins 
 
944.0 
 
1005.5 
 
 
 
 
 
 
3
.
  
Intraday RP-HPLC study indicates that Cefuroxime axetil was undergone moderate 
degradation in alkali hydrolysis and oxidative degradation compared to acid hydrolysis. It 
was observed that bulk was undergone more amount of degradation compared to sample. 
 
 
 
 
 
 
Stress condition 
 
Time Bulk Percentage Content (%) 
Sample percentage 
Content (%) 
0.1N NaOH(Alkali) 90mins  68.7 
 
78.7 
 
0.1N HCl(Acid) 90mins 
 
76.6 
 
78.8 
 
30% H2O2(Oxidation) 90mins 
 
68.8 
 
73.3 
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INTERDAY RP-HPLC STUDY  
Chromatograms for interday study are given in Fig.39-44, Table-18. 
Fig.39 Chromatogram for Cefuroxime axetil Bulk in 0.1N NaOH (3rd day) 
 
 
Fig.40 Chromatogram for Cefuroxime axetil Sample in 0.1N NaOH (3rd day) 
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Fig.41 Chromatogram for Cefuroxime axetil Bulk in 0.1N HCl (3rd day) 
 
 
Fig.42 Chromatogram for Cefuroxime axetil Sample in 0.1N HCl (3rd day) 
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Fig.43 Chromatogram for Cefuroxime axetil Bulk in 30% H2O2 (3rd day) 
 
 
Fig.44 Chromatogram for Cefuroxime axetil Sample in 30% H2O2 (3rd day) 
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 Table: 18 Interday Results for Degradation  
Stress condition 
 
Time Bulk Peak Area Sample Peak Area 
0.1N NaOH(Alkali) 3rd Day  
- 
- 
 
0.1N HCl(Acid) 3
rd
 Day - - 
 
30% H2O2(Oxidation) 3
rd
 Day - - 
 
Thermal (50ºC) 3
rd
 Day  1198.6 
 
1165.0 
 
Sunlight (Photolysis) 3
rd
 Day  1222.2 
 
1128.2 
 
 
Stress condition 
 
Time Bulk Percentage Content (%) 
Bulk Percentage 
Content (%) 
0.1N NaOH(Alkali) 3rd Day - - 
 
0.1N HCl(Acid) 3
rd
 Day - - 
 
30% H2O2(Oxidation) 3
rd
 Day - - 
 
Thermal (50ºC) 3
rd
 Day  87.4 
 
84.9 
 
Sun Light (Photolysis) 3
rd
 Day  89.1 
 
82.2 
 
Complete degradation was observed at the end of 3rd day hydrolytic and oxidative 
degradation. This indicates that Cefuroxime axetil is vulnerable to hydrolytic and 
oxidative degradation. Photolytic and Thermal degradation show only small amount of 
degradation compared to other degradation methods. 
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4. THIN LAYER CHROMATOGRAPHY 
TLC is used for identification of degraded products. The mobile phase used for 
degradation of Cefuroxime axetil was found to be Chloroform and Ethanol in the ratio of 
9:1. Various mobile phases were tried for Cefuroxime axetil. The results of intraday and 
interday are given Table19 and 20 respectively. 
 
Table: 19 Intraday study  
 
STRESS 
CONDITION 
 
SAMPLE 
TYPE 
 
NO OF 
SPOTS 
 
SECONDARY 
SPOTS 
 
Rf VALUE 
 
Alkali Hydrolysis 
0.1N NaOH 
 
Bulk 
 
1 
 
0 
 
0.51 
 
Sample 
 
1 
 
0 
 
0.50 
 
Acid Hydrolysis 
0.1N HCl 
 
Bulk 
 
1 
 
0 
 
0.60 
 
Sample 
 
1 
 
0 
 
0.59 
 
Oxidative 
Degradation 
30% H2O2 
 
Bulk 
 
1 
 
0 
 
0.55 
 
Sample 
 
1 
 
0 
 
0.53 
  
It was observed that there was no major degradation in intraday degradation. No 
secondary spots were observed. The Rf value of standard and sample were found to be 
around 0.55. 
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Table: 20 Interday Degradation Study  
 
 
STRESS 
CONDITION 
 
SAMPLE 
TYPE 
 
NO OF 
SPOTS 
 
SECONDARY 
SPOTS 
 
Rf VALUE 
 
Alkali Hydrolysis 
0.1N NaOH 
 
Bulk 
 
1 
 
0 
 
0.26 
 
Sample 
 
1 
 
0 
 
0.15 
 
Acid Hydrolysis 
0.1N HCl 
 
Bulk 
 
0 
 
0 
 
0 
 
Sample 
 
0 
 
0 
 
0 
 
Oxidative 
Degradation 
30% H2O2 
 
Bulk 
 
1 
 
0 
 
0.98 
 
Sample 
 
0 
 
0 
 
0 
 
Thermal 
Degradation 
 
Bulk 
 
1 
 
0 
 
0.55 
 
Sample 
 
1 
 
0 
 
0.52 
 
Photolytic 
Degradation 
 
Bulk 
 
1 
 
0 
 
0.55 
 
Sample 
 
1 
 
0 
 
0.53 
 
Changes in Rf values were observed in hydrolytic and oxidative degradation. But there 
was no major variation in thermal and photolytic degradation. This shows no major 
degradation in thermal and photolytic degradation. There was no spot observed in bulk, 
sample in acid hydrolysis and sample in oxidative degradation. 
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SUMMARY AND CONCLUSION 
 
The present work entitled as “FORCED DEGRADATION STUDIES OF 
CEFUROXIME AXETIL IN BULK AND FORMULATION BY UV, IR 
SPECTROPHOTOMETRY, TLC, AND RP-HPLC METHOD”.  This study is to 
evaluate the stability of Cefuroxime axetil in bulk and formulation. 
The study includes the following  
 The Alkali hydrolysis, Oxidative degradation, and Thermal and Photolytic 
degradation were performed. 
 Degraded samples were quantified by UV spectroscopy and HPLC. 
 The results of bulk and sample compared with standard. 
 Degraded samples were identified by TLC. 
 Functional group changes in degraded samples were identified by IR. 
 
Quantification of Cefuroxime axetil in bulk and formulation was done by UV 
spectroscopy and HPLC method. 
Interday studies of Photolytic and Thermal degradation was evaluated by IR spectroscopy 
to detect changes in functional group. 
Cefuroxime axetil bulk and formulation were subjected to Hydrolytic degradation, 
Oxidative degradation, Thermal and Photolytic degradation. 
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The main findings of the study are  
Compared to sample, standard has undergone more amount of degradation in intraday 
alkali degradation. 
Complete degradation was observed in interday alkali hydrolytic degradation on 3rd day. 
It indicates that Cefuroxime axetil is vulnerable to alkali hydrolysis. 
Complete degradation was observed in interday acid hydrolytic degradation. It shows 
Cefuroxime axetil is sensitive to acid. 
Oxidative degradative study indicates Cefuroxime axetil is vulnerable to oxidation.   
 
The further scope of study includes 
  To develop and validate a stability indicating method  
  To determine degradation pathways of drug substances and drug products  
(E.g. during development phase)  
  To identify impurities related to drug substances or excipients 
  To understand the drug molecule chemistry  
  To generate more stable formulations. 
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